"MultiCare offers many of the latest cancer treatment methods including surgical robotics, intensity-modulated radiation therapy, full-body stereotactic radiosurgery and image-guided radiation therapy."

During the past decade, MultiCare Regional Cancer Center - Gig Harbor conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MultiCare Regional Cancer Center - Gig Harbor" #1 sponsor was "Alliance Foundation Trials, LLC." with 1 trials, followed by "Astellas Pharma Global Development, Inc." with 1 trials sponsored, "CanariaBio Inc." with 1 trials sponsored, "Candel Therapeutics, Inc." with 1 trials sponsored and "Clovis Oncology, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MultiCare Regional Cancer Center - Gig Harbor" #1 collaborator was "Foundation Medicine" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "MultiCare Regional Cancer Center - Gig Harbor" are "Ovarian Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Prostate Cancer" (2 trials), "Anorexia" (1 trials) and "Blood Clot" (1 trials). Many other conditions were trialed in "MultiCare Regional Cancer Center - Gig Harbor" in a lesser frequency.

Most popular intervention types in "MultiCare Regional Cancer Center - Gig Harbor" are "Drug" (5 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone acetate or Enzalutamide or Docetaxel" (1 trials), "Aglatimagene besadenovec + valacyclovir" (1 trials), "Apixaban" (1 trials), "Carboplatin" (1 trials) and "Collaborative care" (1 trials). Other intervention names were less common.

The vast majority of trials in "MultiCare Regional Cancer Center - Gig Harbor" are 4 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "MultiCare Regional Cancer Center - Gig Harbor". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MultiCare Regional Cancer Center - Gig Harbor, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MultiCare Regional Cancer Center - Gig Harbor, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".